Identification of Biomarkers for Patients with Vascular Anomalies

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID
NCT03001180
Status
Recruiting
Apply to this trial

Conditions

  • Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
  • Generalized Lymphatic Anomaly
  • Gorham-Stout Disease
  • Kaposiform Hemangioendothelioma
  • Kaposiform Lymphangiomatosis
  • Klippel Trenaunay Syndrome
  • Vascular Anomaly

Eligibility Criteria

Sex
ALL
Age
1 Day - N/A
Healthy Volunteers
Not accepted

Study Details

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Key Dates

Start date
Apr 30, 2015
Status verified
Oct 2024
Primary completion
Dec 31, 2050
Completion
Dec 31, 2050

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Correlation of Biomarkers with Differential Diagnosis [ Time Frame: An Average of Every 2 Years ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02115-
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229
Megan Metcalf
[email protected]
513-803-2606
Timothy LeCras, PhD
Adrienne Hammill, MD, PhD

Find similar trials in Boston, MA

By research site
Boston Children's Hospital· Boston, MACincinnati Children's Hospital Medical Center· Cincinnati, OH

Related Studies